While the federal and provincial governments have come to an agreement to provide access to drugs for rare diseases, neither side is addressing much in terms of a pharmacare funding deal.
That leaves Alberta diabetes patients paying the price for that delay, they say.
Lisa Hart, a Type 1 diabetic, is an Albertan whose insurance through work covers continuous glucose monitors for adults.
Her 28-year-old daughter, also a diabetic, doesn’t have such coverage.
“She just doesn’t use it. She can’t afford it,” Hart told CTV News Edmonton on Thursday.
Many adult Albertans are left without coverage, leaving them to pay up to $400 a month for the device plus insulin at 40 dollars a vial.
“I would like to see access to whatever tools and technology are available at no cost,” Hart said. “We got …